Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan T Remaley

Showing results (441-450 of 470) with videos related to

Pageof 47
Sort By:
European Heart Journal|April 29, 2016
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory MedicineBørge G Nordestgaard, Anne Langsted, Samia Mora, et al.
Clinical Chemistry|May 29, 2016
Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory MedicineBørge G Nordestgaard, Anne Langsted, Samia Mora, et al.
The Journal of Biological Chemistry|October 5, 2012
δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disordersMiao Xu, Ke Liu, Manju Swaroop, et al.
Science Translational Medicine|January 31, 2020
A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglyceridesAnna Wolska, Larry Lo, Denis O Sviridov, et al.
Journal of Clinical Lipidology|October 11, 2011
Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialistsMichael H Davidson, Christie M Ballantyne, Terry A Jacobson, et al.
Journal of Clinical Lipidology|February 12, 2015
Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiencyAndreas G Moraitis, Lita A Freeman, Robert D Shamburek, et al.
JCI Insight|September 12, 2023
Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular diseaseAlexander V Sorokin, Christin G Hong, Angel M Aponte, et al.
Analytical Chemistry|October 24, 2013
Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resourcesYamil Simón-Manso, Mark S Lowenthal, Lisa E Kilpatrick, et al.
Clinical Chemistry|May 16, 2018
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLMMichel R Langlois, M John Chapman, Christa Cobbaert, et al.
Frontiers in Cardiovascular Medicine|January 23, 2023
Bayesian network analysis of panomic biological big data identifies the importance of triglyceride-rich LDL in atherosclerosis developmentSzilard Voros, Aruna T Bansal, Michael R Barnes, et al.
Pageof 47

Showing results (441-450 of 470) with videos related to

Sort By:
Pageof 47
European Heart Journal|April 29, 2016
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory MedicineBørge G Nordestgaard, Anne Langsted, Samia Mora, et al.
Clinical Chemistry|May 29, 2016
Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory MedicineBørge G Nordestgaard, Anne Langsted, Samia Mora, et al.
The Journal of Biological Chemistry|October 5, 2012
δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disordersMiao Xu, Ke Liu, Manju Swaroop, et al.
Science Translational Medicine|January 31, 2020
A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglyceridesAnna Wolska, Larry Lo, Denis O Sviridov, et al.
Journal of Clinical Lipidology|October 11, 2011
Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialistsMichael H Davidson, Christie M Ballantyne, Terry A Jacobson, et al.
Journal of Clinical Lipidology|February 12, 2015
Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiencyAndreas G Moraitis, Lita A Freeman, Robert D Shamburek, et al.
JCI Insight|September 12, 2023
Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular diseaseAlexander V Sorokin, Christin G Hong, Angel M Aponte, et al.
Analytical Chemistry|October 24, 2013
Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resourcesYamil Simón-Manso, Mark S Lowenthal, Lisa E Kilpatrick, et al.
Clinical Chemistry|May 16, 2018
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLMMichel R Langlois, M John Chapman, Christa Cobbaert, et al.
Frontiers in Cardiovascular Medicine|January 23, 2023
Bayesian network analysis of panomic biological big data identifies the importance of triglyceride-rich LDL in atherosclerosis developmentSzilard Voros, Aruna T Bansal, Michael R Barnes, et al.
Pageof 47